2/5
08:51 am
mirm
Mirum Pharmaceuticals Announces Health Canada Authorization of LIVMARLI® Tablet Formulation for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome
Medium
Report
Mirum Pharmaceuticals Announces Health Canada Authorization of LIVMARLI® Tablet Formulation for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome
2/5
08:00 am
mirm
Mirum Pharmaceuticals Announces Health Canada Authorization of LIVMARLI® for the Treatment of Cholestatic Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis (PFIC)
Medium
Report
Mirum Pharmaceuticals Announces Health Canada Authorization of LIVMARLI® for the Treatment of Cholestatic Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis (PFIC)
2/3
07:17 am
mirm
Mirum doubles down on diversified rare disease strategy [Yahoo! Finance]
Low
Report
Mirum doubles down on diversified rare disease strategy [Yahoo! Finance]
1/31
03:29 pm
mirm
Is Mirum Pharmaceuticals on a Strong Path to Profitability? [Yahoo! Finance]
Low
Report
Is Mirum Pharmaceuticals on a Strong Path to Profitability? [Yahoo! Finance]
1/30
12:26 pm
mirm
Mirum Pharmaceuticals (NASDAQ:MIRM) had its price target raised by analysts at Morgan Stanley from $95.00 to $123.00. They now have an "overweight" rating on the stock.
Low
Report
Mirum Pharmaceuticals (NASDAQ:MIRM) had its price target raised by analysts at Morgan Stanley from $95.00 to $123.00. They now have an "overweight" rating on the stock.
1/27
06:41 am
mirm
Mirum acquires Bluejay Therapeutics to expand rare liver disease pipeline [Yahoo! Finance]
Low
Report
Mirum acquires Bluejay Therapeutics to expand rare liver disease pipeline [Yahoo! Finance]
1/26
10:46 am
mirm
Mirum Pharmaceuticals Completes Acquisition of Bluejay Therapeutics, Expanding Global Leadership in Rare Disease [Yahoo! Finance]
Low
Report
Mirum Pharmaceuticals Completes Acquisition of Bluejay Therapeutics, Expanding Global Leadership in Rare Disease [Yahoo! Finance]
1/26
08:04 am
mirm
Mirum Pharmaceuticals (NASDAQ:MIRM) had its price target raised by analysts at HC Wainwright from $102.00 to $130.00. They now have a "buy" rating on the stock.
Low
Report
Mirum Pharmaceuticals (NASDAQ:MIRM) had its price target raised by analysts at HC Wainwright from $102.00 to $130.00. They now have a "buy" rating on the stock.
1/26
08:00 am
mirm
Mirum Pharmaceuticals Completes Acquisition of Bluejay Therapeutics, Expanding Global Leadership in Rare Disease
Low
Report
Mirum Pharmaceuticals Completes Acquisition of Bluejay Therapeutics, Expanding Global Leadership in Rare Disease
1/24
02:26 am
mirm
Baird Updates Mirum Pharmaceuticals (MIRM) Valuation Following Beat-and-Raise Earnings Results [Yahoo! Finance]
Low
Report
Baird Updates Mirum Pharmaceuticals (MIRM) Valuation Following Beat-and-Raise Earnings Results [Yahoo! Finance]
1/20
09:05 am
mirm
Mirum Pharmaceuticals (NASDAQ:MIRM) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Low
Report
Mirum Pharmaceuticals (NASDAQ:MIRM) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
1/13
07:17 am
mirm
Mirum Pharmaceuticals (NASDAQ:MIRM) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Mirum Pharmaceuticals (NASDAQ:MIRM) had its "buy" rating reaffirmed by analysts at HC Wainwright.
1/13
05:46 am
mirm
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Low
Report
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
1/13
05:11 am
mirm
3 Top Growth Stocks to Buy in the First Half of 2026 [Yahoo! Finance]
Low
Report
3 Top Growth Stocks to Buy in the First Half of 2026 [Yahoo! Finance]
1/12
05:30 pm
mirm
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1/12
01:06 pm
mirm
Mirum Pharmaceuticals (NASDAQ:MIRM) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Low
Report
Mirum Pharmaceuticals (NASDAQ:MIRM) had its "buy" rating reaffirmed by analysts at Cowen Inc.
1/12
11:37 am
mirm
Mirum Director Sells $400K Amid 91% Stock Surge -- Here's What the Firm Expects for 2026 [Yahoo! Finance]
Low
Report
Mirum Director Sells $400K Amid 91% Stock Surge -- Here's What the Firm Expects for 2026 [Yahoo! Finance]
1/12
08:30 am
mirm
Mirum Pharmaceuticals Announces Preliminary Unaudited 2025 Results, Demonstrating Strong Commercial Growth and Pipeline Momentum
Medium
Report
Mirum Pharmaceuticals Announces Preliminary Unaudited 2025 Results, Demonstrating Strong Commercial Growth and Pipeline Momentum
1/9
11:55 am
mirm
Enthorin Therapeutics Announces Initiation of Phase II Clinical Trial of MRM-3379 (Formerly ENT-3379) for Fragile X Syndrome by Licensing Partner Mirum Pharmaceuticals
Low
Report
Enthorin Therapeutics Announces Initiation of Phase II Clinical Trial of MRM-3379 (Formerly ENT-3379) for Fragile X Syndrome by Licensing Partner Mirum Pharmaceuticals
1/7
04:23 pm
mirm
Mirum Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Mirum Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/7
04:01 pm
mirm
Mirum Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Mirum Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
1/6
08:52 am
mirm
Should You Invest in Mirum Pharmaceuticals (MIRM)? [Yahoo! Finance]
Low
Report
Should You Invest in Mirum Pharmaceuticals (MIRM)? [Yahoo! Finance]
12/30
03:31 am
mirm
Prediction: 3 Stocks That Will Be Worth More Than Newsmax 5 Years From Now [Yahoo! Finance]
Low
Report
Prediction: 3 Stocks That Will Be Worth More Than Newsmax 5 Years From Now [Yahoo! Finance]
12/25
07:00 pm
mirm
What Analysts Think Is Changing the Story for Mirum Pharmaceuticals Now [Yahoo! Finance]
Low
Report
What Analysts Think Is Changing the Story for Mirum Pharmaceuticals Now [Yahoo! Finance]
12/22
03:49 pm
mirm
Mirum Pharmaceuticals: Rich In 2025, Richer (In Promise) In 2026? I Believe So [Seeking Alpha]
Low
Report
Mirum Pharmaceuticals: Rich In 2025, Richer (In Promise) In 2026? I Believe So [Seeking Alpha]